Wayne G Shreffler, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peanut Hypersensitivity | 42 | 2024 | 219 | 8.350 |
Why?
|
Food Hypersensitivity | 37 | 2024 | 726 | 6.260 |
Why?
|
Allergens | 60 | 2024 | 1429 | 5.230 |
Why?
|
Desensitization, Immunologic | 30 | 2024 | 556 | 4.650 |
Why?
|
Immunoglobulin E | 44 | 2024 | 1502 | 3.500 |
Why?
|
Antigens, Plant | 14 | 2023 | 104 | 2.580 |
Why?
|
Th2 Cells | 13 | 2024 | 1056 | 2.560 |
Why?
|
Basophils | 11 | 2022 | 407 | 2.500 |
Why?
|
Milk Hypersensitivity | 13 | 2024 | 82 | 2.150 |
Why?
|
Eosinophilic Esophagitis | 8 | 2024 | 198 | 2.140 |
Why?
|
2S Albumins, Plant | 10 | 2023 | 37 | 2.070 |
Why?
|
Basophil Degranulation Test | 4 | 2019 | 20 | 1.850 |
Why?
|
Anaphylaxis | 9 | 2024 | 757 | 1.660 |
Why?
|
Anti-Allergic Agents | 5 | 2024 | 153 | 1.310 |
Why?
|
Hypersensitivity | 9 | 2024 | 1167 | 1.210 |
Why?
|
Plant Proteins | 9 | 2023 | 369 | 1.050 |
Why?
|
Immunoassay | 5 | 2017 | 744 | 0.980 |
Why?
|
Glycoproteins | 7 | 2015 | 2200 | 0.960 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 4 | 2022 | 799 | 0.940 |
Why?
|
Immune Tolerance | 11 | 2024 | 2299 | 0.910 |
Why?
|
Proctocolitis | 5 | 2023 | 28 | 0.900 |
Why?
|
Complementarity Determining Regions | 2 | 2021 | 149 | 0.770 |
Why?
|
Administration, Oral | 20 | 2024 | 4010 | 0.760 |
Why?
|
Cytokines | 9 | 2024 | 7373 | 0.750 |
Why?
|
Retinal Dehydrogenase | 1 | 2020 | 78 | 0.730 |
Why?
|
Epitope Mapping | 6 | 2011 | 297 | 0.720 |
Why?
|
Adjuvants, Immunologic | 3 | 2012 | 990 | 0.670 |
Why?
|
Hypersensitivity, Immediate | 5 | 2017 | 347 | 0.650 |
Why?
|
Transdermal Patch | 1 | 2019 | 51 | 0.640 |
Why?
|
Skin Tests | 17 | 2023 | 637 | 0.620 |
Why?
|
Immunologic Memory | 3 | 2021 | 1355 | 0.610 |
Why?
|
Immunity, Innate | 6 | 2021 | 3045 | 0.600 |
Why?
|
Microarray Analysis | 4 | 2011 | 748 | 0.590 |
Why?
|
T-Lymphocytes, Regulatory | 5 | 2024 | 3077 | 0.590 |
Why?
|
Epitopes | 10 | 2023 | 2501 | 0.590 |
Why?
|
Antigen-Presenting Cells | 1 | 2020 | 963 | 0.560 |
Why?
|
Diet Therapy | 1 | 2017 | 151 | 0.550 |
Why?
|
Enterocolitis | 3 | 2023 | 106 | 0.520 |
Why?
|
Immunoglobulin G | 10 | 2016 | 4533 | 0.510 |
Why?
|
Flow Cytometry | 4 | 2017 | 5863 | 0.510 |
Why?
|
Metabolomics | 1 | 2024 | 1656 | 0.490 |
Why?
|
Child, Preschool | 44 | 2024 | 42188 | 0.470 |
Why?
|
Food | 6 | 2023 | 768 | 0.470 |
Why?
|
Lymphocyte Subsets | 1 | 2015 | 310 | 0.460 |
Why?
|
Immunization | 3 | 2019 | 1217 | 0.440 |
Why?
|
Child | 53 | 2024 | 80079 | 0.430 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2021 | 2546 | 0.400 |
Why?
|
Vitamin A | 1 | 2015 | 612 | 0.400 |
Why?
|
Milk Proteins | 5 | 2024 | 162 | 0.390 |
Why?
|
Dendritic Cells | 3 | 2020 | 2722 | 0.390 |
Why?
|
Infant Formula | 1 | 2013 | 193 | 0.390 |
Why?
|
Amino Acid Sequence | 5 | 2021 | 13441 | 0.390 |
Why?
|
Feeding Methods | 1 | 2011 | 35 | 0.390 |
Why?
|
Weaning | 1 | 2011 | 103 | 0.380 |
Why?
|
Drug Utilization | 2 | 2014 | 1186 | 0.380 |
Why?
|
Epitopes, B-Lymphocyte | 2 | 2010 | 82 | 0.380 |
Why?
|
Infant Food | 1 | 2011 | 139 | 0.370 |
Why?
|
Humans | 123 | 2024 | 760617 | 0.370 |
Why?
|
Integrins | 1 | 2015 | 834 | 0.360 |
Why?
|
Infant | 32 | 2024 | 36152 | 0.360 |
Why?
|
Vaccines | 1 | 2018 | 838 | 0.330 |
Why?
|
Egg Hypersensitivity | 4 | 2012 | 47 | 0.330 |
Why?
|
Eczema | 3 | 2021 | 246 | 0.320 |
Why?
|
Cesarean Section | 2 | 2014 | 1396 | 0.310 |
Why?
|
Animal Technicians | 2 | 2018 | 7 | 0.310 |
Why?
|
Intestines | 2 | 2014 | 1909 | 0.310 |
Why?
|
Food Labeling | 2 | 2023 | 179 | 0.310 |
Why?
|
Dose-Response Relationship, Immunologic | 4 | 2018 | 360 | 0.310 |
Why?
|
Immunotherapy | 3 | 2024 | 4642 | 0.300 |
Why?
|
Immunomodulation | 2 | 2024 | 548 | 0.300 |
Why?
|
T-Lymphocytes | 4 | 2023 | 10175 | 0.290 |
Why?
|
Epinephrine | 3 | 2024 | 792 | 0.290 |
Why?
|
Dietary Proteins | 3 | 2023 | 951 | 0.280 |
Why?
|
Complement Activation | 1 | 2009 | 445 | 0.280 |
Why?
|
Receptors, IgE | 4 | 2020 | 375 | 0.280 |
Why?
|
Cell Adhesion Molecules | 2 | 2018 | 1602 | 0.270 |
Why?
|
Intestinal Mucosa | 2 | 2016 | 3031 | 0.270 |
Why?
|
Nut Hypersensitivity | 2 | 2019 | 33 | 0.260 |
Why?
|
HLA-DQ Antigens | 1 | 2006 | 191 | 0.260 |
Why?
|
B-Lymphocytes | 2 | 2019 | 4745 | 0.260 |
Why?
|
Antigens, Differentiation | 1 | 2009 | 908 | 0.260 |
Why?
|
Complement System Proteins | 1 | 2009 | 734 | 0.260 |
Why?
|
Antibodies, Monoclonal | 2 | 2019 | 9172 | 0.240 |
Why?
|
Cells, Cultured | 8 | 2024 | 18937 | 0.240 |
Why?
|
Antibody Formation | 2 | 2022 | 1390 | 0.240 |
Why?
|
HLA-DR Antigens | 1 | 2006 | 602 | 0.230 |
Why?
|
Vitamin D | 2 | 2015 | 3302 | 0.230 |
Why?
|
Antibody Specificity | 5 | 2011 | 1058 | 0.230 |
Why?
|
Adolescent | 30 | 2024 | 88234 | 0.230 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2024 | 84 | 0.220 |
Why?
|
Biological Assay | 1 | 2006 | 626 | 0.220 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2024 | 72 | 0.220 |
Why?
|
Male | 54 | 2024 | 360358 | 0.220 |
Why?
|
Animals | 28 | 2024 | 168201 | 0.220 |
Why?
|
Lectins, C-Type | 1 | 2006 | 584 | 0.210 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2024 | 174 | 0.210 |
Why?
|
Lymphocyte Activation | 4 | 2020 | 5463 | 0.210 |
Why?
|
Eicosanoids | 1 | 2024 | 282 | 0.210 |
Why?
|
Administration, Cutaneous | 3 | 2020 | 712 | 0.210 |
Why?
|
Multipotent Stem Cells | 1 | 2024 | 200 | 0.210 |
Why?
|
Eosinophils | 3 | 2018 | 953 | 0.200 |
Why?
|
Bile Acids and Salts | 1 | 2024 | 393 | 0.200 |
Why?
|
Enteritis | 1 | 2023 | 162 | 0.200 |
Why?
|
Algorithms | 4 | 2017 | 14018 | 0.190 |
Why?
|
Gastritis | 1 | 2023 | 199 | 0.190 |
Why?
|
Food Analysis | 1 | 2022 | 103 | 0.190 |
Why?
|
Biological Products | 2 | 2022 | 912 | 0.190 |
Why?
|
Milk | 4 | 2013 | 442 | 0.190 |
Why?
|
Occupational Exposure | 3 | 2018 | 1813 | 0.190 |
Why?
|
Protein Array Analysis | 5 | 2011 | 399 | 0.190 |
Why?
|
Female | 49 | 2024 | 392148 | 0.190 |
Why?
|
Leukocytes, Mononuclear | 2 | 2010 | 1835 | 0.180 |
Why?
|
Immunologic Tests | 1 | 2021 | 104 | 0.180 |
Why?
|
Anti-Asthmatic Agents | 2 | 2016 | 574 | 0.180 |
Why?
|
Aptamers, Nucleotide | 1 | 2022 | 164 | 0.180 |
Why?
|
Double-Blind Method | 8 | 2020 | 12334 | 0.170 |
Why?
|
Receptors, Peptide | 1 | 2021 | 279 | 0.170 |
Why?
|
Child Development | 1 | 2011 | 2300 | 0.170 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2020 | 174 | 0.170 |
Why?
|
Pyrophosphatases | 2 | 2012 | 142 | 0.160 |
Why?
|
Signal Transduction | 2 | 2012 | 23416 | 0.160 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2022 | 351 | 0.160 |
Why?
|
Th1-Th2 Balance | 1 | 2018 | 38 | 0.160 |
Why?
|
Anti-Bacterial Agents | 2 | 2014 | 7402 | 0.160 |
Why?
|
Eosinophilia | 1 | 2023 | 559 | 0.160 |
Why?
|
Serologic Tests | 1 | 2021 | 381 | 0.160 |
Why?
|
Phosphoric Diester Hydrolases | 2 | 2012 | 201 | 0.160 |
Why?
|
Population Groups | 1 | 2019 | 207 | 0.150 |
Why?
|
Lymphokines | 1 | 2021 | 925 | 0.150 |
Why?
|
Endotoxins | 2 | 2017 | 520 | 0.150 |
Why?
|
Seed Storage Proteins | 2 | 2010 | 15 | 0.150 |
Why?
|
Documentation | 1 | 2024 | 895 | 0.150 |
Why?
|
Egg White | 2 | 2008 | 16 | 0.150 |
Why?
|
Tretinoin | 1 | 2020 | 519 | 0.150 |
Why?
|
Peptides | 2 | 2009 | 4354 | 0.140 |
Why?
|
Treatment Outcome | 8 | 2024 | 64568 | 0.140 |
Why?
|
Air Pollutants, Occupational | 2 | 2017 | 407 | 0.140 |
Why?
|
Receptors, Cell Surface | 1 | 2006 | 2802 | 0.140 |
Why?
|
Mast Cells | 3 | 2019 | 1392 | 0.140 |
Why?
|
Confidence Intervals | 2 | 2020 | 2925 | 0.140 |
Why?
|
Biotechnology | 1 | 2018 | 281 | 0.130 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2022 | 974 | 0.130 |
Why?
|
Single-Cell Analysis | 3 | 2022 | 2447 | 0.130 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2019 | 544 | 0.130 |
Why?
|
Cross Reactions | 1 | 2017 | 816 | 0.130 |
Why?
|
Chemokines, CC | 2 | 2013 | 283 | 0.130 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3777 | 0.130 |
Why?
|
Toll-Like Receptor 4 | 1 | 2018 | 578 | 0.120 |
Why?
|
Gastrointestinal Tract | 1 | 2021 | 833 | 0.120 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2022 | 3634 | 0.120 |
Why?
|
Budesonide | 1 | 2015 | 157 | 0.120 |
Why?
|
Sensitivity and Specificity | 5 | 2022 | 14648 | 0.120 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2022 | 4366 | 0.120 |
Why?
|
Asthma | 3 | 2023 | 6233 | 0.110 |
Why?
|
Membrane Proteins | 5 | 2022 | 7847 | 0.110 |
Why?
|
8,11,14-Eicosatrienoic Acid | 1 | 2013 | 64 | 0.110 |
Why?
|
Receptors, CCR8 | 1 | 2013 | 28 | 0.110 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2021 | 1250 | 0.110 |
Why?
|
Transendothelial and Transepithelial Migration | 1 | 2013 | 100 | 0.110 |
Why?
|
Endoscopy, Digestive System | 1 | 2015 | 352 | 0.100 |
Why?
|
Probiotics | 1 | 2016 | 378 | 0.100 |
Why?
|
Respiratory Sounds | 1 | 2017 | 702 | 0.100 |
Why?
|
Eating | 1 | 2019 | 1535 | 0.100 |
Why?
|
Histamine Release | 1 | 2012 | 134 | 0.100 |
Why?
|
Soy Foods | 1 | 2012 | 44 | 0.100 |
Why?
|
Clone Cells | 1 | 2015 | 1657 | 0.100 |
Why?
|
Adult | 23 | 2024 | 220969 | 0.100 |
Why?
|
HEK293 Cells | 1 | 2020 | 4269 | 0.090 |
Why?
|
Monocytes | 1 | 2020 | 2565 | 0.090 |
Why?
|
Juglans | 1 | 2011 | 45 | 0.090 |
Why?
|
Neutrophil Infiltration | 1 | 2013 | 390 | 0.090 |
Why?
|
Cell Differentiation | 3 | 2024 | 11514 | 0.090 |
Why?
|
Drug Synergism | 1 | 2015 | 1755 | 0.090 |
Why?
|
Lens Plant | 1 | 2010 | 5 | 0.090 |
Why?
|
Gene Expression Regulation | 1 | 2009 | 11874 | 0.090 |
Why?
|
Plants | 1 | 2012 | 327 | 0.090 |
Why?
|
Parents | 1 | 2024 | 3563 | 0.090 |
Why?
|
Adrenergic Agonists | 1 | 2009 | 57 | 0.080 |
Why?
|
Antibody Affinity | 1 | 2010 | 246 | 0.080 |
Why?
|
Treatment Failure | 1 | 2015 | 2635 | 0.080 |
Why?
|
Lactoglobulins | 1 | 2008 | 22 | 0.080 |
Why?
|
Up-Regulation | 1 | 2018 | 4117 | 0.080 |
Why?
|
Meat | 1 | 2012 | 584 | 0.080 |
Why?
|
Cell Degranulation | 2 | 2020 | 277 | 0.080 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2023 | 1033 | 0.080 |
Why?
|
Receptors, IgG | 1 | 2012 | 558 | 0.080 |
Why?
|
Caseins | 1 | 2008 | 104 | 0.080 |
Why?
|
Recombinant Proteins | 2 | 2011 | 6520 | 0.080 |
Why?
|
Risk | 2 | 2017 | 9604 | 0.080 |
Why?
|
Interleukin-3 | 1 | 2009 | 425 | 0.070 |
Why?
|
Cattle | 3 | 2024 | 3841 | 0.070 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2009 | 355 | 0.070 |
Why?
|
Nutrition Policy | 1 | 2011 | 466 | 0.070 |
Why?
|
Phytohemagglutinins | 1 | 2006 | 165 | 0.070 |
Why?
|
Mice | 9 | 2024 | 81368 | 0.070 |
Why?
|
Dermatitis, Atopic | 2 | 2011 | 731 | 0.070 |
Why?
|
Gene Expression | 3 | 2015 | 7568 | 0.070 |
Why?
|
Lymphocyte Depletion | 1 | 2009 | 602 | 0.070 |
Why?
|
Urticaria | 1 | 2008 | 150 | 0.070 |
Why?
|
Age Factors | 2 | 2021 | 18381 | 0.070 |
Why?
|
Folic Acid | 1 | 2013 | 1323 | 0.070 |
Why?
|
Mitogens | 1 | 2006 | 229 | 0.070 |
Why?
|
Cell Proliferation | 2 | 2015 | 10432 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8516 | 0.070 |
Why?
|
Computational Biology | 1 | 2018 | 3509 | 0.070 |
Why?
|
Urban Population | 2 | 2017 | 2033 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4571 | 0.060 |
Why?
|
Glucocorticoids | 1 | 2015 | 2160 | 0.060 |
Why?
|
Pseudomonas aeruginosa | 1 | 2013 | 1272 | 0.060 |
Why?
|
Young Adult | 11 | 2024 | 59179 | 0.060 |
Why?
|
Antigen-Antibody Reactions | 1 | 2005 | 340 | 0.060 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 2006 | 284 | 0.060 |
Why?
|
Blood Specimen Collection | 1 | 2006 | 238 | 0.060 |
Why?
|
Vitamins | 1 | 2013 | 1635 | 0.060 |
Why?
|
Intestinal Absorption | 1 | 2006 | 400 | 0.060 |
Why?
|
Syndrome | 2 | 2023 | 3268 | 0.060 |
Why?
|
Lipopolysaccharides | 2 | 2017 | 2202 | 0.060 |
Why?
|
Thyroid Diseases | 1 | 2008 | 386 | 0.060 |
Why?
|
Environmental Exposure | 2 | 2017 | 4483 | 0.060 |
Why?
|
Ligands | 2 | 2013 | 3268 | 0.060 |
Why?
|
Prognosis | 2 | 2019 | 29600 | 0.060 |
Why?
|
United States | 6 | 2024 | 72272 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2022 | 22148 | 0.050 |
Why?
|
Reference Standards | 1 | 2006 | 1002 | 0.050 |
Why?
|
Environment | 1 | 2009 | 1123 | 0.050 |
Why?
|
Immunologic Factors | 2 | 2022 | 1589 | 0.050 |
Why?
|
Antigen Presentation | 1 | 2008 | 1250 | 0.050 |
Why?
|
Coculture Techniques | 1 | 2006 | 1336 | 0.050 |
Why?
|
Molecular Sequence Data | 4 | 2010 | 17629 | 0.050 |
Why?
|
Powders | 1 | 2021 | 80 | 0.050 |
Why?
|
Emollients | 1 | 2021 | 42 | 0.050 |
Why?
|
Antibodies, Viral | 2 | 2024 | 3150 | 0.050 |
Why?
|
Cryopreservation | 1 | 2006 | 728 | 0.050 |
Why?
|
Risk Factors | 7 | 2022 | 74115 | 0.050 |
Why?
|
Antigens | 1 | 2006 | 1441 | 0.050 |
Why?
|
Vaccination | 2 | 2024 | 3370 | 0.050 |
Why?
|
RNA, Messenger | 3 | 2024 | 12758 | 0.050 |
Why?
|
Prevalence | 1 | 2017 | 15689 | 0.040 |
Why?
|
Nuts | 1 | 2022 | 264 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7389 | 0.040 |
Why?
|
T-Lymphocyte Subsets | 1 | 2008 | 1798 | 0.040 |
Why?
|
No-Observed-Adverse-Effect Level | 1 | 2019 | 25 | 0.040 |
Why?
|
Fetal Blood | 1 | 2006 | 1347 | 0.040 |
Why?
|
Neuraminidase | 1 | 2020 | 195 | 0.040 |
Why?
|
Cell Line | 4 | 2019 | 15576 | 0.040 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2019 | 84 | 0.040 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2019 | 109 | 0.040 |
Why?
|
Prospective Studies | 6 | 2023 | 54360 | 0.040 |
Why?
|
Immunity, Humoral | 1 | 2024 | 600 | 0.040 |
Why?
|
Regression Analysis | 2 | 2020 | 6338 | 0.040 |
Why?
|
Health Promotion | 1 | 2011 | 2206 | 0.040 |
Why?
|
ROC Curve | 2 | 2021 | 3575 | 0.040 |
Why?
|
Epithelial Cells | 2 | 2013 | 3672 | 0.040 |
Why?
|
Quality of Life | 2 | 2017 | 13347 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2022 | 978 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2022 | 534 | 0.040 |
Why?
|
Antigens, CD | 2 | 2006 | 3998 | 0.040 |
Why?
|
Occult Blood | 1 | 2020 | 197 | 0.040 |
Why?
|
Cohort Studies | 4 | 2015 | 41457 | 0.040 |
Why?
|
Infant, Newborn | 4 | 2023 | 26180 | 0.040 |
Why?
|
Hyperplasia | 1 | 2021 | 1150 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2005 | 2700 | 0.040 |
Why?
|
Palatine Tonsil | 1 | 2019 | 193 | 0.040 |
Why?
|
Hot Temperature | 3 | 2010 | 1437 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39063 | 0.040 |
Why?
|
Animals, Laboratory | 1 | 2017 | 46 | 0.040 |
Why?
|
Models, Immunological | 1 | 2020 | 512 | 0.040 |
Why?
|
Middle Aged | 10 | 2024 | 220584 | 0.040 |
Why?
|
Respiratory System | 1 | 2021 | 563 | 0.040 |
Why?
|
Diet | 1 | 2015 | 8048 | 0.040 |
Why?
|
Galectin 3 | 1 | 2019 | 240 | 0.040 |
Why?
|
Plant Extracts | 1 | 2021 | 497 | 0.040 |
Why?
|
Glycosylation | 1 | 2020 | 1098 | 0.030 |
Why?
|
Medical History Taking | 1 | 2021 | 773 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2019 | 883 | 0.030 |
Why?
|
Conjunctivitis, Allergic | 1 | 2017 | 125 | 0.030 |
Why?
|
Interleukin-4 | 2 | 2010 | 1146 | 0.030 |
Why?
|
Protein Binding | 2 | 2022 | 9345 | 0.030 |
Why?
|
Autoimmune Diseases | 1 | 2008 | 2238 | 0.030 |
Why?
|
Th1 Cells | 1 | 2021 | 1027 | 0.030 |
Why?
|
Respiratory Hypersensitivity | 1 | 2017 | 274 | 0.030 |
Why?
|
Placebo Effect | 1 | 2019 | 518 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 10199 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2014 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15828 | 0.030 |
Why?
|
Th17 Cells | 1 | 2021 | 793 | 0.030 |
Why?
|
Cities | 1 | 2017 | 546 | 0.030 |
Why?
|
Dust | 1 | 2017 | 487 | 0.030 |
Why?
|
Maine | 1 | 2013 | 146 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2008 | 3415 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12447 | 0.030 |
Why?
|
Apoptosis | 1 | 2009 | 9476 | 0.030 |
Why?
|
Research Design | 1 | 2009 | 6174 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2023 | 1936 | 0.030 |
Why?
|
Odds Ratio | 2 | 2017 | 9643 | 0.030 |
Why?
|
Leukotriene B4 | 1 | 2013 | 280 | 0.030 |
Why?
|
DNA | 1 | 2006 | 7196 | 0.030 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2013 | 378 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2020 | 80566 | 0.020 |
Why?
|
Housing | 1 | 2017 | 669 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1661 | 0.020 |
Why?
|
HIV Infections | 1 | 2018 | 17337 | 0.020 |
Why?
|
Administration, Sublingual | 1 | 2011 | 59 | 0.020 |
Why?
|
Models, Biological | 2 | 2018 | 9461 | 0.020 |
Why?
|
Eggs | 1 | 2012 | 182 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2013 | 661 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2013 | 696 | 0.020 |
Why?
|
Peroxidase | 1 | 2013 | 610 | 0.020 |
Why?
|
Chemotaxis | 1 | 2013 | 598 | 0.020 |
Why?
|
Respiratory Mucosa | 1 | 2013 | 438 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2020 | 2315 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2018 | 1201 | 0.020 |
Why?
|
Laboratories | 1 | 2013 | 458 | 0.020 |
Why?
|
Forecasting | 1 | 2019 | 2924 | 0.020 |
Why?
|
Interleukin-5 | 1 | 2010 | 269 | 0.020 |
Why?
|
Weight Gain | 1 | 2020 | 2350 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2009 | 18221 | 0.020 |
Why?
|
Ovomucin | 1 | 2008 | 7 | 0.020 |
Why?
|
Cell Survival | 1 | 2018 | 5780 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6474 | 0.020 |
Why?
|
Nanoparticles | 1 | 2019 | 1957 | 0.020 |
Why?
|
Pruritus | 1 | 2010 | 378 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9529 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9313 | 0.020 |
Why?
|
Ovalbumin | 1 | 2008 | 675 | 0.020 |
Why?
|
Egg Proteins, Dietary | 1 | 2006 | 6 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2022 | 9417 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10548 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 14591 | 0.020 |
Why?
|
Cell Movement | 1 | 2018 | 5200 | 0.020 |
Why?
|
Phylogeny | 1 | 2013 | 2806 | 0.020 |
Why?
|
Transfection | 1 | 2013 | 5766 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2017 | 20074 | 0.020 |
Why?
|
Age of Onset | 1 | 2012 | 3302 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2006 | 17878 | 0.010 |
Why?
|
Disease Progression | 1 | 2021 | 13495 | 0.010 |
Why?
|
Morbidity | 1 | 2009 | 1750 | 0.010 |
Why?
|
Pregnancy | 2 | 2020 | 29868 | 0.010 |
Why?
|
Biomedical Research | 1 | 2019 | 3426 | 0.010 |
Why?
|
Protein Conformation | 1 | 2010 | 3965 | 0.010 |
Why?
|
Aged | 3 | 2020 | 169042 | 0.010 |
Why?
|
Phenotype | 2 | 2011 | 16571 | 0.010 |
Why?
|
Down-Regulation | 1 | 2009 | 2915 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22115 | 0.010 |
Why?
|
Calcium | 1 | 2013 | 5717 | 0.010 |
Why?
|
Models, Molecular | 1 | 2010 | 5433 | 0.010 |
Why?
|
Feces | 1 | 2006 | 1490 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4570 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10754 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23972 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58894 | 0.010 |
Why?
|
Inflammation | 1 | 2013 | 10760 | 0.010 |
Why?
|
Incidence | 1 | 2009 | 21337 | 0.010 |
Why?
|